413
$50M$100M
460$50M$100M
108
334$50M$100M
283$50M$100M
90$10M$50M
11$10M
13$10MvTv Therapeutics uses 8 technology products and services including Drupal, Google Font API, React, and more. Explore vTv Therapeutics's tech stack below.
| vTv Therapeutics Email Formats | Percentage |
| FLast@vtvtherapeutics.com | 49% |
| First@vtvtherapeutics.com | 1% |
| F_Last@vtvtherapeutics.com | 1% |
| FLast@vtvtherapeutics.com | 49% |
Pharmaceutical ManufacturingNorth Carolina, United States11-50 Employees
vTv Therapeutics is a clinical stage biopharmaceutical company focused on developing oral, small molecule drug candidates. vTv has a pipeline of clinical drug candidates led by cadisegliatin, a potential adjunctive therapy to insulin for the treatment of type 1 diabetes. vTv and its development partners are pursuing additional indications, including type 2 diabetes and other chronic conditions.
Company Overview
Funding & FinancialsvTv Therapeutics has raised a total of $51M of funding over 5 rounds. Their latest funding round was raised on Feb 28, 2024 in the amount of $51M.
vTv Therapeutics's revenue is in the range of $10M
Funding & FinancialsvTv Therapeutics has raised a total of $51M of funding over 5 rounds. Their latest funding round was raised on Feb 28, 2024 in the amount of $51M.
vTv Therapeutics's revenue is in the range of $10M
1-888-653-2347 
support@leadiq.com